0
Skip to Content
Lactiga | Advancing Immunotherapy | Pioneering sIgA Antibody Science | Mucosal Immunity, Redefined | Biotech for the Immune Frontier | Therapeutics Inspired by Human Milk
About
Pipeline
Media & Investors
In the News
Podcasts
Awards & Announcements
For Human Milk Banks
Contact
Lactiga | Advancing Immunotherapy | Pioneering sIgA Antibody Science | Mucosal Immunity, Redefined | Biotech for the Immune Frontier | Therapeutics Inspired by Human Milk
About
Pipeline
Media & Investors
In the News
Podcasts
Awards & Announcements
For Human Milk Banks
Contact
About
Pipeline
Folder: Media & Investors
Back
In the News
Podcasts
Awards & Announcements
For Human Milk Banks
Contact
In vivo antiviral efficacy of LCTG-002, a pooled, purified human milk secretory IgA product, against SARS-CoV-2 in a murine model of COVID-19
Publications, In the News Rik Mehta 9/25/23 Publications, In the News Rik Mehta 9/25/23

In vivo antiviral efficacy of LCTG-002, a pooled, purified human milk secretory IgA product, against SARS-CoV-2 in a murine model of COVID-19

Read More

About us
Pipeline
For Human Milk Banks
Contact

Follow us

Explore

Sign up with your email address to receive news and updates.

Thank you!

Privacy Policy | Terms of Use

Copyright © 2025 Lactiga US, Inc. | All rights reserved.